SCHEMBL13428105

SCHEMBL13428105

Cc1cc(C)cc(-c2c3ccc(N4c5ccccc5CCc5ccccc54)cc3c(-c3cc(C)cc(C)c3)c3ccc(N4c5ccccc5CCc5ccccc54)cc23)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
SMN1; SMN2 Q16637 4/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HPGD P15428 1/20 0.33
LMNA P02545 1/20 0.33
NPSR1 Q6W5P4 1/20 0.32
SLC6A2 P23975 2/20 0.32
HSD17B3 P37058 2/20 0.32
TP53 P04637 1/20 0.32
NFKB1 P19838 1/20 0.32
NFKB2 Q00653 1/20 0.32
RELA Q04206 1/20 0.32
SRD5A1 P18405 2/20 0.31
GAA P10253 1/20 0.31
TLR9 Q9NR96 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13428104 0.92 SMN1; SMN2 (0.37) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL13008759 0.92 MAPT (0.37) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL13428164 0.91 ALDH1A1 (0.34) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL13428194 0.89 POLB (0.34) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL13428107 0.88 ACHE (0.36) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL13540152 0.86
SCHEMBL13009027 0.85 HSD17B3 (0.36) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL13008864 0.85 HSD17B3 (0.36) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2
SCHEMBL13008855 0.84 PGR (0.34)
SCHEMBL13008440 0.84 SMN1; SMN2 (0.36) ALDH1A1MAPTKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A ALDH1A1 1477/4885MAPT 3713/4885KMT2A 2323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.